I attended my high school reunion and had no anxiety about appearance,” Sarah gushed. “My new problem was graciously ...

Novo Nordisk shares fell nearly 30% in the fourth quarter on disappointing clinical trial data, and other concerns. Bank of ...

GlobalData has named heart failure as the next disease to feel the sales-boosting power of GLP-1 drugs. The analysts expect ...

Researchers from Canada reviewed the results of 26 trials to determine which of the weight loss jabs are the most effective ...

New tests may show how much value a particular obese patient will get for a GLP-1 agonist prescription dollar.

As 2025 ushers in a new era of weight loss resolutions, many Americans are abandoning traditional gym-first approaches in ...

A range of GLP-1 weight loss drugs are currently on the market. What are they, what do they do, and where are they available?

By comparison, the FDA-approved drug liraglutide only resulted in just under 6% weight loss after 26 weeks, the researchers found. Common adverse side effects from the drugs included nausea, vomiting, ...

A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic. Experts ...

Dr. Mehmet Furkan Burak said people who have lost weight and then gained it again can feel guilt or shame and blame ...

Ozempic and Wegovy are two popular injectable medications for weight loss and diabetes. But what’s the difference?

Investing.com - Novo Nordisk (CSE: NOVOb ) remains the "most exciting growth story" in the European pharmaceutical sector and ...